AMSBIO introduces new range of research grade biosimilars
AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to […]
Stephanie Eisenbarth, MD, PhD, has been named chief of Feinberg's Division of Allergy and Immunology in the Department of Medicine, […] Following on from a thorough review of the evidence carried out by the MHRA, and recommendation by the Commission on […] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the coronaviru2019 (COVID-19) pandemic, has already infected about […] Researchers from the University of Oxford have today released their findings about the so-called ‘correlates of protection’ against symptomatic COVID-19; […] Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are […] Researchers at Children's Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in […] The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a respiratory virus with […] The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […]antibody
World renowned immunologist named chief of Feinberg's Division of Allergy and Immunology
MHRA approves first monoclonal antibody treatment for COVID-19 in the UK
Moderna COVID-19 vaccine safe and efficacious in adolescents according to a new study
Identified: Levels of antibody protection required to prevent symptomatic COVID-19
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
CHOP researchers identify key target responsible for treatment failure in patients with hemophilia A
Measurable antibody response to mRNA COVID-19 vaccine in elderly care home residents
Living with a COVID-19 case brings worse symptoms and stronger antibody response
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response